Literature DB >> 10713905

[Genetic risk factors for myocardial infarct].

D H Walter1, A M Zeiher.   

Abstract

Interactions of genetic and environmental risk factors influence the susceptibility to coronary artery disease (CAD) and myocardial infarction. In myocardial infarction occurring at young age, genetics of this multifactorial disease may be the leading factor. A number of candidate genes have been implicated in the pathogenesis of CAD and myocardial infarction. Mutations in the DNA sequence (gene polymorphisms) have been identified that appear to play a crucial role in blood pressure regulation, lipid metabolism, endothelial function, in the pathophysiology of coagulation or thrombosis, or in interventional cardiology by interfering with restenosis development. Genetic polymorphisms seem to be clinically important because they not only potentiate the individual risk under certain circumstances, but they also determine safety and effectiveness of commonly prescribed drugs. Understanding the complexity and functional relevance of genetic risk factors will be useful in early detection and treatment of individuals that are exposed to higher risk for myocardial infarction. Thus it is important to include genetic risk factors in the concept of the classical risk factor theory. Potentially in future a genetic risk profile including relevant polymorphisms may be an essential part of the clinicians' knowledge in primary and secondary prevention of coronary artery disease.

Entities:  

Mesh:

Year:  2000        PMID: 10713905     DOI: 10.1007/BF03044119

Source DB:  PubMed          Journal:  Herz        ISSN: 0340-9937            Impact factor:   1.740


  72 in total

1.  Association of the platelet Pl(A) polymorphism of glycoprotein IIb/IIIa and the fibrinogen Bbeta 448 polymorphism with myocardial infarction and extent of coronary artery disease.

Authors:  A M Carter; N Ossei-Gerning; I J Wilson; P J Grant
Journal:  Circulation       Date:  1997-09-02       Impact factor: 29.690

2.  The 4G/5G polymorphism in the plasminogen activator inhibitor-1 gene is not associated with myocardial infarction.

Authors:  C J Doggen; R M Bertina; V M Cats; P H Reitsma; F R Rosendaal
Journal:  Thromb Haemost       Date:  1999-07       Impact factor: 5.249

Review 3.  Atherosclerosis--an inflammatory disease.

Authors:  R Ross
Journal:  N Engl J Med       Date:  1999-01-14       Impact factor: 91.245

Review 4.  Update on low density lipoprotein receptor mutations.

Authors:  A K Soutar
Journal:  Curr Opin Lipidol       Date:  1998-04       Impact factor: 4.776

5.  Polymorphism of the NADH/NADPH oxidase p22 phox gene in patients with coronary artery disease.

Authors:  N Inoue; S Kawashima; K Kanazawa; S Yamada; H Akita; M Yokoyama
Journal:  Circulation       Date:  1998-01-20       Impact factor: 29.690

Review 6.  Endothelial vasodilator dysfunction: pathogenetic link to myocardial ischaemia or epiphenomenon?

Authors:  A M Zeiher
Journal:  Lancet       Date:  1996-11       Impact factor: 79.321

7.  Prediction of coronary heart disease using risk factor categories.

Authors:  P W Wilson; R B D'Agostino; D Levy; A M Belanger; H Silbershatz; W B Kannel
Journal:  Circulation       Date:  1998-05-12       Impact factor: 29.690

8.  Apolipoprotein(a) kringle IV repeat number predicts risk for coronary heart disease.

Authors:  H G Kraft; A Lingenhel; S Köchl; F Hoppichler; F Kronenberg; A Abe; V Mühlberger; D Schönitzer; G Utermann
Journal:  Arterioscler Thromb Vasc Biol       Date:  1996-06       Impact factor: 8.311

9.  Angiotensin-converting enzyme and apolipoprotein E genotypes and restenosis after coronary angioplasty.

Authors:  F M van Bockxmeer; C D Mamotte; F A Gibbons; V Burke; R R Taylor
Journal:  Circulation       Date:  1995-10-15       Impact factor: 29.690

Review 10.  [Genetic factors in the development of atherosclerosis].

Authors:  J Thiery; D Teupser
Journal:  Z Kardiol       Date:  1998-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.